GlaxoSmithKline (GSK)
Industry
Pharmaceuticals
Corporate Headquarters
London, United Kingdom
Corporate Profits, 2005-2024
$163.5 billion
Find an oligarch
Spending Snapshot
Campaign Spending
$25.3million
From Employees: 0.5%
Lobbying Spending
$9.9million
Total Political Spending
$35.2million
Issues
- Spent $17.1 million to oppose Prop. 79 (Defeated, 2005) (and support the competing Prop. 78 (Defeated, 2005)) to prevent the reduction of prescription drug prices
- Spent $6.2 million to oppose Prop. 61 (Defeated, 2016), which would have reduced prescription drug prices
- Lobbied against bills that sought to ensure the safety, effectiveness, and affordability of prescription drugs, including: SB-606 (Defeated, 2007-08), AB-463 (Defeated, 2015-16)
- Gave $553K to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $553K to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $553K to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $553K to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $553K to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $553K to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
Republicans
$46.4k
Democrats
$74.4k
Total - All Current Elected Officials
$121.8k
Pharmaceutical Research and Manufacturers of America California Initiative Fund: OPPOSED: PROP 79 - PRESCRIPTION DRUG DISCOUNTS. STATE-NEGOTIATED REBATES. | SUPPORTED: PROP 78 - PRESCRIPTION DRUGS. DISCOUNTS.
$17.1 million
No on Prop 61 - Californians Against the Deceptive Rx Proposition, a Coalition of Veterans Doctors Patient Advocates Seniors Taxpayers and Members of Pharmaceutical Research and Manufacturers of America: OPPOSED: PROPOSITION 061- STATE PRESCRIPTION DRUG PURCHASES. PRICING STANDARDS.
$6.2 million
Pharmaceutical Research and Manufacturers of America Independent Expenditure Committee
$553.0k
